- Trials with a EudraCT protocol (39)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (5)
39 result(s) found for: Herpes simplex virus.
Displaying page 1 of 2.
EudraCT Number: 2007-000182-38 | Sponsor Protocol Number: ACYCLOVIR LP 01/06 | Start Date*: 2007-07-26 | |||||||||||
Sponsor Name:MIPHARM | |||||||||||||
Full Title: EFFICACY AND SAFETY OF A NEW TOPICAL FORMULATION OF ACYCLOVIR GEL (LP) IN THE TREATMENT OF HERPES SIMPLEX LABIALIS A RANDOMIZED, Single-BLIND, MULTICENTER, CONTROLLED CLINICAL TRIAL ve... | |||||||||||||
Medical condition: Subjects with a clinical diagnosis of Herpes Simplex Labialis on the perioral area. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005010-12 | Sponsor Protocol Number: CFAM810B2301 | Start Date*: 2007-04-02 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A multicenter, open-label, single-arm study to evaluate the single-dose pharmacokinetics, acceptability and safety of famciclovir oral pediatric formulation in infants 1 month to <1 year of age wit... | |||||||||||||
Medical condition: herpes simplex or varicella zoster virus infections in infants 1 month to <1 year of age | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005835-14 | Sponsor Protocol Number: Acyclovir01/08 | Start Date*: 2008-11-26 | |||||||||||
Sponsor Name:MIPHARM | |||||||||||||
Full Title: Efficacy and tolerability of a new topical formulation of Acyclovir gel (Acyclorir Liquipatch) given 3 times/day in the treatment of herpes simplex labialis. An open-label, blind controlled, random... | |||||||||||||
Medical condition: Herpes Simplex Labialis on the perioral area | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001572-11 | Sponsor Protocol Number: LLB-2019-01 | Start Date*: 2020-08-05 | |||||||||||||||||||||
Sponsor Name:LABO’LIFE Belgium sprl | |||||||||||||||||||||||
Full Title: Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LHERP® in patients with recurrent genital herpes infections. | |||||||||||||||||||||||
Medical condition: Patients presenting recurrent genital herpes infections (4 or more episodes within the 12-months’ period prior to their study entry). | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: BE (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000549-38 | Sponsor Protocol Number: LIP-01-01 | Start Date*: 2018-01-29 | |||||||||||
Sponsor Name:Laboratorios Ojer Pharma S.L. | |||||||||||||
Full Title: An open-label study to investigate the local tolerability and acceptability of Lipovir® Gel (Acyclovir 5%) compared to Zovirax® Cream (Acyclovir 5%) on patients with Recurrent Herpes Labialis | |||||||||||||
Medical condition: Herpes labialis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002135-26 | Sponsor Protocol Number: 4PH/2011/002 | Start Date*: 2012-02-16 | |||||||||||
Sponsor Name:AESCULAPIUS FARMACEUTICI S.R.L. | |||||||||||||
Full Title: Efficacy and Safety of Acyclovir 5 Lipstick (Contra) in Treatment of Skin Infections Provoked by Herpes Simplex. A Randomised, Double-blind, Placebo Controlled, Parallel Group Study. | |||||||||||||
Medical condition: History of recurrent herpes labialis with at least 3 recurrences during the past 12 months and typically (>50% of episodes) associated with prodromal symptoms | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003586-35 | Sponsor Protocol Number: 215336 | Start Date*: 2022-01-25 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:GlaxoSmithKline Biologicals SA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A Phase I/II, observer-blind, randomised, placebo controlled, multi-country study to evaluate reactogenicity, safety, immune response, and efficacy of an HSV-targeted immunotherapy in healthy parti... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Recurrent genital herpes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: BE (Trial now transitioned) DE (Trial now transitioned) ES (Ongoing) EE (Ongoing) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004835-19 | Sponsor Protocol Number: 38RC16.015 | Start Date*: 2017-07-20 | |||||||||||
Sponsor Name:University Hospital Grenoble | |||||||||||||
Full Title: Dexamethasone in Herpes Simplex Virus Encephalitis Open label Randomized Controlled Trial with an Observer-blinded evaluation at 6 months | |||||||||||||
Medical condition: HSV encephalitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000880-26 | Sponsor Protocol Number: HTX101-02G | Start Date*: 2019-09-03 | |||||||||||
Sponsor Name:Heidelberg ImmunoTherapeutics GmbH | |||||||||||||
Full Title: A Randomized, Double-Blind, Double-Dummy Phase II Study of Single Dose HDIT101 versus Standard of Care Valaciclovir in Patients with Chronic Recurrent Anogenital HSV-2 Infection | |||||||||||||
Medical condition: Chronic recurrent anogenital HSV-2 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000926-24 | Sponsor Protocol Number: HTX101-03L | Start Date*: 2020-08-17 | ||||||||||||||||
Sponsor Name:Heidelberg ImmunoTherapeutics | ||||||||||||||||||
Full Title: A Randomised, Double-Blind Phase II Trial of Topical HDIT101 versus Placebo in Patients with Chronic Recurrent HSV-1 Infection and Orolabial Lesion | ||||||||||||||||||
Medical condition: Chronic Herpes Simplex Virus-1 Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) AT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-004316-31 | Sponsor Protocol Number: FPP4-DE-401 | Start Date*: 2009-02-23 | |||||||||||
Sponsor Name:Novartis Consumer Health S.A. | |||||||||||||
Full Title: A randomised, double-blind, vehicle controlled, single centre, parallel group, comparative study of the efficacy of penciclovir 10 mg/g (1%) cream in preventing the appearance of classical lesions ... | |||||||||||||
Medical condition: Cold Sores caused by the herpes simplex virus (HSV) type 1. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001451-30 | Sponsor Protocol Number: UMCN-AKF12.07 | Start Date*: 2019-06-17 | |||||||||||
Sponsor Name:Radboud university medical center | |||||||||||||
Full Title: Pharmacokinetics of a new paediatric formulation of valacyclovir used for prophylaxis and treatment of VZV and HSV infections in children, phase II (VALID II) | |||||||||||||
Medical condition: Herpes virus infections, especially Herpes Simplex and Varicella Zoster. | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023156-89 | Sponsor Protocol Number: V212-011 | Start Date*: 2011-02-24 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., Inc | |||||||||||||
Full Title: Ensayo clínico en fase III, aleatorizado y controlado con placebo para estudiar la seguridad y la eficacia de V212 en pacientes adultos con tumor sólido o neoplasia hematológica. A Phase III Rando... | |||||||||||||
Medical condition: Incidence of Herpes Zoster in adults with solid tumor or hematologic malignancy Incidencia de Herpes Zoster en pacientes adultos con tumor sólido o neoplasia hematológica. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) DE (Completed) CZ (Completed) GB (Completed) SK (Completed) AT (Completed) BE (Completed) EE (Completed) LT (Completed) GR (Completed) BG (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004441-17 | Sponsor Protocol Number: CFAM810B2303 | Start Date*: 2016-04-12 |
Sponsor Name:Novartis Pharmaceuticals | ||
Full Title: A Multicenter, Open-label, Single-arm, Two-step Study to Evaluate the Safety and Single-dose Pharmacokinetics of Famciclovir and Multiple-dose Safety After Administration of Famciclovir Oral Pediat... | ||
Medical condition: Herpes Simplex | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2005-001705-26 | Sponsor Protocol Number: CYD-GER-0401 | Start Date*: 2005-09-21 |
Sponsor Name:Spirig Pharma AG | ||
Full Title: Efficacy and safety of topically applied cyclodextrin gel (Spirig Pharma) in the treatment of recurrent genital herpes simplex virus infections: a randomised, double-blind, placebo-controlled, mult... | ||
Medical condition: Genito-anal herpes simplex infections | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003201-81 | Sponsor Protocol Number: GFVT01026904 (GACHE) | Start Date*: 2006-12-20 |
Sponsor Name:Universitätsklinikum Heidelberg | ||
Full Title: GACHE: German trial of Acyclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis. A multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial. | ||
Medical condition: Herpes simplex virus type-1 (HSV-1) is the most frequent cause of fatal sporadic encephalitis in humans. Herpes simplex encephalitis (HSE) was one of the first viral infections to be successfully t... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-000577-22 | Sponsor Protocol Number: AKF-UMCN11.05 | Start Date*: 2012-07-17 | |||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | |||||||||||||
Full Title: Palatability testing of a new paediatric formulation of valacyclovir for the prophylaxis and treatment of VZV and HSV infections in children – VALID 0 | |||||||||||||
Medical condition: Herpes virus infections, especially Herpes Simplex, Varicella Zoster and Cytomegalovirus | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006940-69 | Sponsor Protocol Number: 601 | Start Date*: 2010-05-20 |
Sponsor Name:Lund University Hospital | ||
Full Title: Add-on treatment of mental illness with anti-viral medicine | ||
Medical condition: Schizophrenia, bipolar disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004869-88 | Sponsor Protocol Number: HS2116100 | Start Date*: 2016-12-21 |
Sponsor Name:GlaxoSmithKline K.K. (GSK) | ||
Full Title: A multicenter, open-label study to evaluate preventive efficacy for herpes simplex virus infection and safety of 256U87 (valaciclovir hydrochloride) in adult and pediatric hematopoietic stem cell t... | ||
Medical condition: Herpes simplex virus (HSV) infection before and after hematopoietic stem cell transplantation. | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2019-001085-15 | Sponsor Protocol Number: LLB-2018-01 | Start Date*: 2019-11-06 | |||||||||||||||||||||
Sponsor Name:LABO’LIFE Belgium sprl | |||||||||||||||||||||||
Full Title: Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LHERP® in patients with recurrent orofacial herpes infections. | |||||||||||||||||||||||
Medical condition: Patients presenting recurrent orofacial herpes infections (6 or more episodes within the 12-months’ period prior to their study entry). | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: BE (Trial now transitioned) | |||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
